Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
about
The pathogenesis of lyme neuroborreliosis: from infection to inflammationOne-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferiA host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen.Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme DiseaseBorreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme diseaseThe Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental MiceOral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection.Lyme arthritis: current concepts and a change in paradigm.Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine developmentSignificantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspCRapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease.Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.
P2860
Q24670918-AF0951F5-9C49-4DC0-BDA3-BC70FDFC822AQ33825744-221D7980-EC47-4AC3-B301-C4F8ECA2268EQ34797227-B3F0699A-745E-481C-986E-BC6D6147E149Q35112976-EA299B51-F96D-4CCB-AD5D-D0356A98B2C1Q35773884-5D571A3B-3CC6-46EB-AD5D-7D59DC1B1595Q35783597-DE1385D0-B820-473D-9C46-FA32682DF7A0Q35915376-F4E61735-A671-4B02-A52F-2B020A8BCA21Q35962468-24CF6EBA-5A2A-447D-B7E1-5747F24DF874Q37001131-99A46891-9A07-4BA8-9E33-2623700E5BC6Q37099227-EC0EA25C-C81E-4B2F-8C35-9DB21FBAB312Q37563638-263664B3-5701-4D42-9D73-C97A96EF8755Q38499117-241570B6-9A10-4E62-A134-1D6E9AE03A13Q39754996-DADD2900-FDA7-4052-A762-20EEFE48A7EFQ41856040-67196247-AFA9-4D47-9DD2-4BD3124F086AQ45417527-9E59ED8C-271F-4B4A-A276-8E9B2106DDCBQ51159971-2091808D-7B38-4589-9EE4-BB97466DF626
P2860
Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Borreliacidal OspC antibodies ...... not occur in mice or hamsters.
@ast
Borreliacidal OspC antibodies ...... not occur in mice or hamsters.
@en
type
label
Borreliacidal OspC antibodies ...... not occur in mice or hamsters.
@ast
Borreliacidal OspC antibodies ...... not occur in mice or hamsters.
@en
prefLabel
Borreliacidal OspC antibodies ...... not occur in mice or hamsters.
@ast
Borreliacidal OspC antibodies ...... not occur in mice or hamsters.
@en
P2093
P2860
P1476
Borreliacidal OspC antibodies ...... not occur in mice or hamsters.
@en
P2093
Dean A Jobe
Ronald F Schell
Steven D Lovrich
Steven M Callister
P2860
P304
P356
10.1128/CDLI.12.6.746-751.2005
P577
2005-06-01T00:00:00Z